GSDME and hepatocellular carcinoma: The two independent clusters and the 5-PRG risk score, which integrated pyroptosis and immunological features with GSDME, NOD1, PLCG1, NLRP6 and NLRC4, could reliably predict prognosis and immunotherapy response in HCC patients.